We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Quantitative Appraisal of Ventricular Cerebrospinal Fluid Biomarkers in Neuropathologically Diagnosed Parkinson's Disease Cases Lacking Alzheimer's Disease Pathology.
- Authors
Maarouf, Chera L.; Beach, Thomas G.; Adler, Charles H.; Malek-Ahmadi, Michael; Kokjohn, Tyler A.; Dugger, Brittany N.; Walker, Douglas G.; Shill, Holly A.; Jacobson, Sandra A.; Sabbagh, Marwan N.; Roher, Alex E.
- Abstract
Identifying biomarkers that distinguish Parkinson's disease (PD) from normal control (NC) individuals has the potential to increase diagnostic sensitivity for the detection of early-stage PD. A previous proteomic study identified potential biomarkers in postmortem ventricular cerebrospinal fluid (V-CSF) from neuropathologically diagnosed PD subjects lacking Alzheimer's disease (AD) neuropathology. In the present study, we assessed these biomarkers as well as p-tau181, Aβ42, and S100B by ELISA in PD (n = 43) and NC (n = 49) cases. The p-tau181/Aβ42 ratio and ApoA-1 showed statistically significant differences between groups. Multiple regression analysis demonstrated that p-tau181/Aβ42 had a significant odds ratio: OR = 1.42 (95% confidence interval [CI], 1.12-1.84), P = 0.006. Among the molecules investigated, intriguing correlations were observed that require further investigation. Our results suggest co-existent AD CSF biomarkers within the PD group notwithstanding that it was selected to minimize AD neuropathological lesions.
- Subjects
CEREBROSPINAL fluid; BIOMARKERS; PARKINSON'S disease diagnosis; ALZHEIMER'S disease; MULTIPLE regression analysis; NEUROLOGICAL disorders
- Publication
Biomarker Insights, 2013, Issue 8, p19
- ISSN
1177-2719
- Publication type
Article
- DOI
10.4137/BMI.S11422